Earl B. Ettienne, BSc Pharm, MBA, DLP.
White House Fellow
Dr. Earl B. Ettienne is a nationally recognized pharmacy executive, educator, scholar, and policy strategist whose career spans academia, industry, government, and global health. He currently serves as Associate Professor and Assistant Dean of Graduate Programs and Industrial
Partnerships at Howard University College of Pharmacy, where his work exemplifies Howard’s mission to develop leaders who tackle pressing healthcare challenges through equity, innovation, and global impact.
A licensed pharmacist with more than 30 years of cross-sector experience, Dr. Ettienne is the founder and architect of the Howard University nationally ranked Pharmaceutical Industry Fellowship (HUPIF) Program. Under his visionary leadership, HUPIF has partnered with more than 16 corporations to place and mentor over 100 fellows, securing millions in programmatic funding and establishing one of the nation’s strongest pipelines for pharmaceutical industry talent.
Dr. Ettienne’s research and scholarship focus on addressing health disparities through pharmacogenomics, regulatory science, and precision public health. His NIH-funded work includes pioneering studies on the CYP3A4 gene’s role in opioid use disorder among African American patients and the integration of genomic testing in the management of diabetes and depression. His publications and translational projects—extending from the United States to Ghana—have shaped clinical guidelines and informed policy reform across multiple jurisdictions.
A transformative educator, Dr. Ettienne teaches pharmacy administration, drug development, pharmaceutical policy, and regulatory affairs, consistently earning recognition for outstanding pedagogy and mentorship. His students and fellows regularly achieve distinction at Howard University Research Day and beyond, a testament to his ability to connect rigorous academic training with national and global healthcare imperatives.
Dr. Ettienne is a sought-after thought leader and advocate, contributing testimony before Congress, advising federal and state agencies, and appearing on Bloomberg News, CNBC, WHUT, Maryland Public Television, C-SPAN, Pharmacy Times, and Chain Drug Review. His dedication has been honored with the Charlie Van Der Horst Sacrificial Leadership Award, the Cardinal Health GenerationRx Champions Award, and the Cultivate Leadership Award from the Young Black Pharmaceutical Professionals.
His service to the academy includes leadership as Co-Chair of Howard’s Institutional Review Board, President Emeritus of the Pharmacy Alumni Association, and reviewer for Pharmacogenomics, JAPhA, and other leading journals. He has spearheaded curriculum redesign in pharmacy administration, regulatory affairs, and policy, while forging strategic partnerships across Africa and the Caribbean to expand Howard’s global research footprint.
A scholar with a profound sense of calling, Dr. Ettienne continues to bridge the legacy of Historically Black Colleges and Universities with the future of biomedical science—preparing students not only to enter the workforce, but to lead it.
White House Fellow
Dr. Earl B. Ettienne is a nationally recognized pharmacy executive, educator, scholar, and policy strategist whose career spans academia, industry, government, and global health. He currently serves as Associate Professor and Assistant Dean of Graduate Programs and Industrial
Partnerships at Howard University College of Pharmacy, where his work exemplifies Howard’s mission to develop leaders who tackle pressing healthcare challenges through equity, innovation, and global impact.
A licensed pharmacist with more than 30 years of cross-sector experience, Dr. Ettienne is the founder and architect of the Howard University nationally ranked Pharmaceutical Industry Fellowship (HUPIF) Program. Under his visionary leadership, HUPIF has partnered with more than 16 corporations to place and mentor over 100 fellows, securing millions in programmatic funding and establishing one of the nation’s strongest pipelines for pharmaceutical industry talent.
Dr. Ettienne’s research and scholarship focus on addressing health disparities through pharmacogenomics, regulatory science, and precision public health. His NIH-funded work includes pioneering studies on the CYP3A4 gene’s role in opioid use disorder among African American patients and the integration of genomic testing in the management of diabetes and depression. His publications and translational projects—extending from the United States to Ghana—have shaped clinical guidelines and informed policy reform across multiple jurisdictions.
A transformative educator, Dr. Ettienne teaches pharmacy administration, drug development, pharmaceutical policy, and regulatory affairs, consistently earning recognition for outstanding pedagogy and mentorship. His students and fellows regularly achieve distinction at Howard University Research Day and beyond, a testament to his ability to connect rigorous academic training with national and global healthcare imperatives.
Dr. Ettienne is a sought-after thought leader and advocate, contributing testimony before Congress, advising federal and state agencies, and appearing on Bloomberg News, CNBC, WHUT, Maryland Public Television, C-SPAN, Pharmacy Times, and Chain Drug Review. His dedication has been honored with the Charlie Van Der Horst Sacrificial Leadership Award, the Cardinal Health GenerationRx Champions Award, and the Cultivate Leadership Award from the Young Black Pharmaceutical Professionals.
His service to the academy includes leadership as Co-Chair of Howard’s Institutional Review Board, President Emeritus of the Pharmacy Alumni Association, and reviewer for Pharmacogenomics, JAPhA, and other leading journals. He has spearheaded curriculum redesign in pharmacy administration, regulatory affairs, and policy, while forging strategic partnerships across Africa and the Caribbean to expand Howard’s global research footprint.
A scholar with a profound sense of calling, Dr. Ettienne continues to bridge the legacy of Historically Black Colleges and Universities with the future of biomedical science—preparing students not only to enter the workforce, but to lead it.
